Aggressive childhood cancer could be treated by combining DNA-damage-targeting drugs
An aggressive form of the childhood cancer neuroblastoma could be treatable with two cancer drugs currently used in the treatment […]
» Read moreThe results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment option for patients with metastatic […] An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of […] Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. […] Delays and cancelation of cancer treatments and other safety measures undertaken to minimize the risk of exposure to the coronavirus […] Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some […] (HealthDay)—The risk for cancer is reduced among patients with multiple sclerosis (MS), according to a systematic review and meta-analysis published […] Bowel cancer is one of the most common cancers to be diagnosed in the UK. You should consider speaking to […] Dad-of-one Graham Wood, 36, has terminal brain cancer and when he was diagnosed in 2015, he was told he would […] Breast cancer rates among women globally are on the rise, but new research is uncovering trends related to age and […]
New first-line treatment option for metastatic kidney cancer
Immunotherapy improves survival in advanced bladder cancer patients
Study reveals how cannabinoids may be useful to prevent colon cancer
COVID-19 pandemic halts cancer care and damages oncologists’ well-being
New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Risk for cancer reduced for patients with multiple sclerosis
Bowel cancer warning: Does your poo sink or float? Hidden signs of a tumour in the toilet
Dad with terminal cancer fundraises for son diagnosed with life-limiting illness
Study finds global trends in women’s breast cancer show cause for concern
